Hikma Pharmaceuticals

Manufacture of basic pharmaceutical products · London

Hikma Pharmaceuticals

Hikma Pharmaceuticals Public Limited Company

Photo: Basher Eyre · CC BY-SA 2.0
ActiveLatest figures: 2025Group consolidated21 years on the register

Public limited company registered in London, classed under “Manufacture of basic pharmaceutical products”.

Headline figures

FY to Dec 2025 · Group consolidated

Turnover

For subscribers

Profit after tax

$407m

Net assets

For subscribers

Cash

For subscribers

Employees

For subscribers

Retained reserves

For subscribers

What the numbers say

3 findings from the figures, in plain English

Written by rules from the figures on this page. Not a forecast or a credit opinion.

History

Pro
US$202320242025
Profit after tax$407m
Turnover
Net assets
Cash
Employees
Retained reserves

Every figure for all 3 years

“—” means we did not find the figure in a source; it is never filled with an estimate.

Balance sheet and ratios

From the filed balance sheets · €

Balance sheet202320242025
Current assets
of which cash
Creditors due within a year
Creditors due after a year
Net assets
Ratios
Profit marginProfit after tax as a share of turnover
Return on equityProfit after tax as a share of net assets
Current ratioCurrent assets for every £1 owed within a year
Cash ratioCash for every £1 owed within a year

5 balance-sheet lines and 4 ratios, every year

A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.

Timeline

Checked 2026-10-18

  1. Shares
    Cancellation of shares. Statement of capital on 25 August 2026 · GBP 22,162,866.00 (and 32 more like it since 28 April 2026)
  2. Shares
    Purchase of own shares (and 25 more like it since 8 April 2026)
  3. Directors
    Director's details changed for Mazen Samih Darwazah on 8 September 2005
  4. Directors
    Appointment of Mr Tobias Hannes Hestler as a director on 7 August 2026
  5. Address
    Registered office address changed from 10 Portman Square 10 Portman Square London W1H 6AZ England to 10 Portman Square London W1H 6AZ on 29 July 2026
  6. Directors
    Director's details changed for Ms Victoria Mary Hull on 17 July 2026
  7. Directors
    Director's details changed for Dr Deneen Vojta on 18 May 2026 (and 1 more like it since 19 May 2026)
  8. Directors
    Director's details changed for Ms Victoria Mary Hull on 18 May 2026
  9. Directors
    Director's details changed for Ms Laura Mihaela Balan on 18 May 2026
  10. Directors
    Director's details changed for Mr Douglas Malcolm Hurt on 18 May 2026
  11. Directors
    Secretary's details changed for Mrs Helen Middlemist on 18 May 2026
  12. Address
    Registered office address changed from 1 New Burlington Place London W1S 2HR United Kingdom to 10 Portman Square 10 Portman Square London W1H 6AZ on 18 May 2026
  13. 18 earlier
    1. Filing
      Resolutions (and 2 more like it since 2 May 2024)
    2. Accounts
      Group of companies' accounts made up to 31 December 2025
    3. Directors
      Director's details changed for Ms Victoria Mary Hull on 30 June 2025
    4. Directors
      Termination of appointment of Mary Regina Henderson as a director on 31 December 2025
    5. Directors
      Appointment of Mr Khalid Walid Hussni Nabilsi as a director on 15 December 2025
    6. Directors
      Termination of appointment of Riad Ali Mishlawi as a director on 15 December 2025
    7. Address
      Register inspection address has been changed
    8. Accounts
      Group of companies' accounts made up to 31 December 2024
    9. Directors
      Termination of appointment of John Julius Castellani as a director on 24 April 2025
    10. Shares
      Statement of capital following an allotment of shares on 10 June 2024 · GBP 23,471,968.6 (and 6 more like it since 4 September 2023)
    11. Accounts
      Group of companies' accounts made up to 31 December 2023
    12. Directors
      Termination of appointment of Patrick Noel Butler as a director on 29 February 2024
    13. Directors
      Director's details changed for Ms Victoria Hull on 7 February 2024
    14. Directors
      Appointment of Mrs Helen Middlemist as a secretary on 1 January 2024
    15. Directors
      Termination of appointment of Hussein Omar Arkhagha as a secretary on 1 January 2024
    16. Directors
      Appointment of Mr Riad Ali Mishlawi as a director on 1 September 2023
    17. Directors
      Director's details changed for Ali Mohammed Al Husry on 17 July 2023
    18. Accounts
      Group of companies' accounts made up to 31 December 2022

From the Companies House filing history. Routine confirmation statements are left out, and a run of the same filing is shown once.

Questions people ask

›What does Hikma Pharmaceuticals do?

Public limited company registered in London, classed under “Manufacture of basic pharmaceutical products”. In its own words: “Hikma is a leading global pharmaceutical company that manufactures high-quality generic medicines and makes them accessible to people who need them.”

›How much turnover does Hikma Pharmaceuticals make?

Answered in the full report

›Is Hikma Pharmaceuticals profitable?

Yes: it made a profit after tax of $407m in the year to 31 December 2025, its latest filed accounts.

›Who runs and owns Hikma Pharmaceuticals?

Its directors are Helen Middlemist, Ali Mohammed Al Husry, Laura Mihaela Balan, Said Samih Darwazah, Mazen Samih Darwazeh and 6 more. Its owners are shown to subscribers.

›Where is Hikma Pharmaceuticals based?

Its registered office is 10 Portman Square, London, W1H 6AZ, in London.

›When was Hikma Pharmaceuticals founded?

Hikma Pharmaceuticals Public Limited Company was incorporated on 8 September 2005.

›Is Hikma Pharmaceuticals still trading?

The register lists Hikma Pharmaceuticals Public Limited Company as active.

More companies in London →